- A. Health Biotechnology
- Areas of activity
- Therapeutic areas
- Genetic and rare diseases
At Minoryx, we are committed to finding novel treatments for life threatening rare diseases. We prioritize pediatric diseases and we are currently focused on neurometabolic diseases of genetic origin.
Minoryx develops a new generation of non-competitive pharmacological chaperones through a proprietary technological platform. As a complementary approach, Minoryx also progress repositioning-based projects.